Establishment Labs Holdings Inc. (NasdaqCM: ESTA)
Health Care · Health Care Equipment & Supplies · US
$60.74
-1.51% today · +53.7% 1Y
Establishment Labs Holdings Inc. (NasdaqCM: ESTA) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.84B and employs 1,004 people.
Over the last twelve months the share price has gained 53.7%, trading between 38.38 and 97.59.
Tweenvest scores Establishment Labs Holdings Inc. across four factors: quality 42/100, value 79/100, growth 100/100. Its strongest factor is growth.
ESTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.84B
- Revenue (TTM)
- $245.82M
- P/E
- —
- EPS
- -1.29
- Dividend yield
- —
- Beta (5Y)
- 1.06
- 52-week high
- $97.59
- 52-week low
- $38.38
- Avg volume (3M)
- —
- Shares outstanding
- 29.80M
- Employees
- 1,004
- Next earnings
- —
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
- ISIN
- VGG312491084
- Founded
- 2004
- Listed since
- Jul 19, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Insight Lifetech Co., Ltd.SHSE: 688712 | $1.89B | CN¥30.30 | -2.01% |
| LeMaitre Vascular, Inc.NasdaqGM: LMAT | $1.85B | $82.66 | +2.44% |
| Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.SZSE: 301093 | $1.84B | CN¥58.00 | -8.10% |
| MeHow Innovative Ltd.SZSE: 301363 | $1.84B | CN¥15.52 | -4.49% |
| Implantica AGOM: IMP A SDB | $1.83B | Skr64.60 | -14.10% |
| Tofflon Science and Technology Group Co., Ltd.SZSE: 300171 | $1.81B | CN¥15.96 | -2.86% |
| Shandong Pharmaceutical Glass Co.LtdSHSE: 600529 | $1.81B | CN¥18.28 | +0.61% |
| Angelalign Technology Inc.SEHK: 6699 | $1.79B | HK$82.30 | -1.08% |
Figures last refreshed Oct 11, 2026.